Data requested- no response from GSK. Changes in bronchial hyperreactivity induced by four weeks treatment with anti asthma drugs in patients with allergic asthma. Data not presented for each group and phase. FEV1- baseline pre treatment, post treatment 16 wks, possibly available at 4, and 8 weeks FVC- baseline pre treatment, post treatment 16 wks, possibly available at 4, and 8 weeks FEF baseline pre treatment, post treatment 16 wks, possibly available at 4, and 8 weeks PEF morning- average for treatment period from weeks? Multicentre GSK sponsored study.
No differences were detected in the remaining sessions. Corticoidrs, single centre study in Canada. No response to request. Two-year bronchodilator treatment in ejemplos de corticoides inhalados with mild airflow obstruction; Contradictory effects on lung function and quality of life. Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol. Ambos revisores obtuvieron los datos y realizaron evaluaciones de calidad.
Parallel group, multicentre, 15 centres Canada. No placebo group, subjects not blinded, investigators not blinded. A comparison between short-acting and long-acting beta2-agonists. PC20 methacholine, post txt and run out. A comparison of four weeks treatment with fenoterol and terbutaline aeroslos in adult asthmatics.
Iamges: ejemplos de corticoides inhalados
Effectsof long term inhaled salbutamol therapy on the provocation of asthma by histamine. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma. Not an RCT- no randomisation, no placebo control- experimental observations. Mild-moderate, step BTS guidelines asthma management. Change of asthma medication or exacerbations asthma or hospitalization for asthma within 4 weeks.
Ambos revisores obtuvieron los datos y realizaron evaluaciones de calidad. Changes in bronchial reactivity in asthmatic children after treatment with beclomethasone alone or in combination with salbutamol. No formal randomisation, no blinding, small numbers, confounding by high withdrawl rates. Parallel group, randomly allocated , double blind study. Increased inhaled bronchodilator versus increased inhaled corticosteroid in the control of moderate asthma.
The figures for those having at least one major exacerbation and those requiring at least one course of oral corticosteroids were available. Unable to combine data in the format presented. No placebo group, subjects not ejemplos de corticoides inhalados, investigators not blinded. Evaluation of tolerance after continuous and prolonged oral administration of salbutamol to asthmatic patients. Not RCT, outcomes not measured. Increased bronchial hyperesponsiveness after inhaling salbutamol during one year is not caused by subsensitisation to salbutamol. A comparison with salbutamol achat sustanon 250 placebo.